EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular detection of isoniazid and rifampin-resistant Mycobacterium tuberculosis strains from southwest of Iran

Nazanin Ahmad Khosravi, Azar Dokht Khosravi, Mehrandokht Sirous, Mohammad Hashemzadeh, Homayoun Amiri, Shokrollah Salmanzadeh, Seyed Mohammad Alavi, Zohreh Deilami, Maryam Mohsenpoor, Meisam Movahedi

European Journal of Clinical and Experimental Medicine · 25.06.2026 · 24 (2)

DOI: 10.15584/ejcem.2026.2.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical and Experimental Medicine, online erschienen am 25.06.2026. Verfasst von Nazanin Ahmad Khosravi und 9 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aim. The study of molecular mechanisms of resistance to first-line antibiotics for the treatment of tuberculosis is of great importance. Investigating these mechanisms provides valuable information to treatment policy makers. Therefore, this study aimed to identify mutations associated with resistance to rifampin (RIF) and isoniazid (INH) among drug-resistant Mycobacterium tuberculosis (MTB) isolates from a TB reference center in southwest Iran. Material and methods. In this cross-sectional study (September 2014-February 2018), a total of 772 MTB isolates were confirmed by culture on Löwenstein-Jensen (LJ) medium and standard biochemical tests. Drug susceptibility testing of RIF and INH was determined by the proportion method on LJ medium. Mutations conferring resistance to INH and RIF were determined by polymerase chain reaction analysis and sequencing.

Results

In this study, 772 (22.68%) MTB strains were isolated from 3,404 TB-suspected patients, of whom 26.6% were women and 73.8% male. Of the 772 clinical strains, 8 (1.03%) were MDR (resistant to INH and RIF), 15 (1.94%) were resistant to RIF and 4 (0.5%) were resistant to INH. Of the 12 identified isolates identified (including both 4 isolates resistant to INH and 8 isolates resistant to MDR), 2 (16.6%) had a mutation at codon 315 of katG, 1 (8.33%) had a mutation at (-15) of inhA, and 9 (75%) did not show a detectable mutation. Regarding rifampin, the frequency of mutations in the rpoB gene was the following: codons 531 (n=7, 30.4%), 533 (n=5, 21.7%), 526 (n = 2, 8.69%) and 511 (n=1, 4.3%). Furthermore, no mutations were detected in 8 (34.7%) isolates.

Conclusion

The most prevalent mutation in INH resistant isolates was at codon 315 of katG. In RIF-resiatant isolates, the most prevalent mutation was at codon 531 of the rpoB gene. In a considerable number of isolates, no mutations in katG, inhA, and rpoB were found compared with deposited sequences available from NCBI GenBank.

Zitieren

APA

Khosravi, N. A., Khosravi, A. D., Sirous, M., Hashemzadeh, M., Amiri, H., Salmanzadeh, S., Alavi, S. M., Deilami, Z., Mohsenpoor, M., & Movahedi, M. (2026). Molecular detection of isoniazid and rifampin-resistant Mycobacterium tuberculosis strains from southwest of Iran. European Journal of Clinical and Experimental Medicine, 24(2). https://doi.org/10.15584/ejcem.2026.2.15

Vancouver

Khosravi NA, Khosravi AD, Sirous M, Hashemzadeh M, Amiri H, Salmanzadeh S, et al. Molecular detection of isoniazid and rifampin-resistant Mycobacterium tuberculosis strains from southwest of Iran. European Journal of Clinical and Experimental Medicine. 2026;24(2). doi:10.15584/ejcem.2026.2.15

BibTeX
@article{Khosravi2026,
  author = {Khosravi, Nazanin Ahmad and Khosravi, Azar Dokht and Sirous, Mehrandokht and Hashemzadeh, Mohammad and Amiri, Homayoun and Salmanzadeh, Shokrollah and Alavi, Seyed Mohammad and Deilami, Zohreh and Mohsenpoor, Maryam and Movahedi, Meisam},
  title = {Molecular detection of isoniazid and rifampin-resistant Mycobacterium tuberculosis strains from southwest of Iran},
  journal = {European Journal of Clinical and Experimental Medicine},
  year = {2026},
  volume = {24},
  number = {2},
  doi = {10.15584/ejcem.2026.2.15}
}
Kostenlos starten →